FDA
approval
· 2022-01-27
FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., expanding the drug's approved indications. The actio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LAMPIT (NIFURTIMOX)